Expansion of Production Facilities and Strengthening of Research and Development Capabilities
First written in FY2016. 24 of 36 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2024: 1 of 7 companies on the "Worse" side.
4 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Research and development expenses for the current fiscal year were ¥312,941 thousand.」
R&D expenses amounted to ¥312.941 million, up from ¥256.807 million in the previous fiscal year. - FY2026-H1AdvancedAnnual report
「The company's R&D activities totaled ¥152.426 million for the interim accounting period.」
R&D expenses for the interim accounting period amounted to ¥152.426 million, up from ¥117.935 million in the same period of the previous year. - FY2025AdvancedAnnual report
「R&D expenses for the fiscal year amounted to ¥256.807 million.」
R&D expenses for the fiscal year amounted to ¥256.807 million, up from ¥241.703 million in the previous fiscal year. The company continued its R&D activities. - FY2025-H1RestatedAnnual report
「The company's R&D activities totaled ¥117.935 million for the interim accounting period.」
The company continued its R&D activities and recorded R&D expenses of ¥117.935 million for the interim accounting period. - FY2024AdvancedAnnual report
「Capital expenditures during the fiscal year, including leased assets and intangible fixed assets, totaled ¥648.583 million, and R&D expenses amounted to ¥241.703 million.」
The company continued to expand its production facilities and enhance its R&D capabilities, recording capital expenditures of ¥648.583 million and R&D expenses of ¥241.703 million. - FY2024-Q3RestatedAnnual report
「The company's R&D activities totaled ¥182.054 million for the cumulative period through the third quarter.」
The company continued its R&D activities and recorded R&D expenses of ¥182.054 million for the cumulative period through the third quarter. - FY2024-Q2RestatedAnnual report
「The company's R&D activities totaled ¥119.365 million for the cumulative period through the second quarter.」
The company continued its R&D activities and recorded R&D expenses of ¥119.365 million for the cumulative period through the second quarter. - FY2024-Q1RestatedAnnual report
「The company's R&D activities totaled ¥59.642 million for the cumulative period through the first quarter.」
The company continued its R&D activities and recorded R&D expenses of ¥59.642 million for the cumulative period through the first quarter. - FY2023AdvancedAnnual report
「R&D expenses for the fiscal year amounted to ¥237.373 million.」
The company continued its R&D activities and recorded R&D expenses of ¥237.373 million for the fiscal year. The details of development related to the environment and energy, information and communications, and advanced materials have also been made more specific. - FY2023-Q3RestatedAnnual report
「The company's R&D activities totaled ¥173.258 million for the cumulative period through the third quarter.」
The company continued its R&D activities and recorded R&D expenses of ¥173.258 million for the cumulative period through the third quarter. - FY2023-Q2RestatedAnnual report
「The company's R&D activities totaled ¥109.674 million for the cumulative period through the second quarter.」
The company continued its R&D activities and recorded cumulative R&D expenses of ¥109.674 million from April through September 2022. - FY2023-Q1RestatedAnnual report
「The company's R&D activities totaled ¥53.869 million for the cumulative period through the first quarter.」
The company continued its R&D activities and recorded R&D expenses of ¥53.869 million for the cumulative period through the first quarter. - FY2022-Q2RestatedAnnual report
「The company's R&D activities totaled ¥105.676 million for the cumulative period through the second quarter.」
The company continued its R&D activities and recorded R&D expenses of ¥105.676 million for the cumulative period through the second quarter. - FY2022-Q1RestatedAnnual report
「The company's R&D activities totaled ¥47.630 million for the cumulative period through the first quarter.」
The company continued its R&D activities and recorded R&D expenses of ¥47.630 million for the cumulative period through the first quarter. - FY2021AdvancedAnnual report
「R&D expenses for the fiscal year amounted to ¥216.068 million.」
The company continued its R&D activities and recorded R&D expenses of ¥216.068 million for the fiscal year. It also incurred ¥941.972 million in capital expenditures. - FY2021-Q3RestatedAnnual report
「The company's R&D activities totaled ¥163.902 million for the cumulative period through the third quarter.」
The company continued its R&D activities and recorded R&D expenses of ¥163.902 million for the cumulative period through the third quarter. - FY2021-Q2RestatedAnnual report
「The company's R&D activities totaled ¥101.433 million for the cumulative period through the second quarter.」
The company continued its R&D activities and recorded R&D expenses of ¥101.433 million for the cumulative period through the second quarter. - FY2021-Q1RestatedAnnual report
「The company's R&D activities totaled ¥46.821 million for the cumulative period through the first quarter.」
The company continued its R&D activities and recorded R&D expenses of ¥46.821 million for the cumulative period through the first quarter. - FY2020AdvancedAnnual report
「Capital expenditures during the fiscal year, including leased assets and intangible fixed assets, totaled ¥1,951.245 million. Capital expenditures by segment are as follows.」
The company continued to expand and renew its production facilities and enhance its R&D capabilities, investing ¥1,951.245 million in capital expenditures during the fiscal year. R&D expenses totaled ¥219.477 million. - FY2020-Q3RestatedAnnual report
「The company's R&D activities totaled ¥163.931 million for the cumulative period through the third quarter.」
The company continued its R&D activities and recorded R&D expenses of ¥163.931 million for the cumulative period through the third quarter. - FY2020-Q2RestatedAnnual report
「The company's R&D activities totaled ¥108.204 million for the cumulative period through the second quarter.」
The company continued its R&D activities and recorded R&D expenses of ¥108.204 million for the cumulative period through the second quarter. - FY2020-Q1RestatedAnnual report
「The company's R&D activities totaled ¥50.673 million for the cumulative period through the first quarter.」
The company continued its R&D activities and recorded R&D expenses of ¥50.673 million for the cumulative period through the first quarter. - FY2019AdvancedAnnual report
「Capital expenditures for the fiscal year totaled ¥870.154 million, including intangible fixed assets, and R&D expenses amounted to ¥212.846 million.」
The company continued to expand and renew its production facilities and enhance its R&D capabilities, incurring capital expenditures of ¥870.154 million and R&D expenses of ¥212.846 million. - FY2019-Q3RestatedAnnual report
「Total spending on research and development activities during the cumulative third quarter was ¥135.077 million.」
The company continued its R&D activities and recorded R&D expenses of ¥135.077 million for the cumulative period through the third quarter. - FY2019-Q2RestatedAnnual report
「Total spending on research and development activities during the cumulative second quarter was ¥101.426 million.」
Research and development activities continued, with total spending of ¥101.426 million recorded for the cumulative second quarter. - FY2019-Q1RestatedAnnual report
「Total spending on research and development activities during the cumulative first quarter was ¥49.424 million.」
Research and development activities continued, with research and development expenses of ¥49.424 million recorded for the cumulative first quarter. - FY2018AdvancedAnnual report
「Total capital investment for the fiscal year was ¥711.370 million, including intangible assets,」
The company made ¥711.370 million in capital investments during the fiscal year to expand production facilities and enhance and strengthen research and development capabilities. The medium-term plan also calls for increased production capacity for zirconia balls, piezoelectric materials and components for next-generation batteries. - FY2018-Q3RestatedAnnual report
「Total spending on research and development activities during the cumulative third quarter was ¥150.144 million.」
Research and development activities continued, with total spending of ¥150.144 million recorded for the cumulative third quarter. - FY2018-Q2RestatedAnnual report
「Total spending on research and development activities during the cumulative second quarter was ¥99.942 million.」
The company continued its research and development activities and recorded research and development expenses of ¥99.942 million for the cumulative second quarter. - FY2018-Q1RestatedAnnual report
「Total spending on research and development activities during the cumulative first quarter was ¥48.293 million.」
The company continued its research and development activities and recorded research and development expenses of ¥48.293 million for the cumulative first quarter. - FY2017-Q3RestatedAnnual report
「Total spending on research and development activities during the cumulative third quarter was ¥147.173 million.」
Research and development activities continued, with research and development expenses of ¥147.173 million recorded for the cumulative third quarter. - FY2017-Q2RestatedAnnual report
「Total spending on research and development activities during the cumulative second quarter was ¥98.704 million.」
Research and development activities continued, with research and development expenses of ¥98.704 million recorded for the cumulative second quarter. - FY2017-Q1RestatedAnnual report
「Total spending on research and development activities during the cumulative first quarter was ¥49.683 million.」
Research and development activities continued, with research and development expenses of ¥49.683 million recorded for the cumulative first quarter. - FY2016First statedAnnual report
「During the fiscal year, we continued to make capital investments aimed at expanding production facilities and enhancing and strengthening research and development capabilities. Total capital investment for the fiscal year was ¥457.653 million, including intangible assets,」
Investment in production facilities and research and development capabilities continued, with capital investment of ¥457.653 million recorded for the fiscal year.